EVAg

Cygnet River virus HA protein antiserum (Rabbit #606)

Eubenangee virus VP7 antiserum (Rabbit #798)

Hendra virus N protein antiserum (Rabbit #369)

Hendra virus G protein antiserum (Rabbit #615)

Avian influenza A virus NP antiserum (Rabbit #690)

Kunjin virus NS1 antiserum (Rabbit #17)

Lumpy skin disease virus LSDV074 (p32) protein antiserum (Rabbit #27J)

Lumpy skin disease virus p32 monoclonal antibody IgG2a (25F3.A3.D9)

Menangle virus N protein antiserum (Rabbit)

Nelson Bay virus mu (μ) protein antiserum (Rabbit #672)

Nelson Bay virus sigma (σ) protein antiserum (Rabbit #658)

Nelson Bay virus lambda (λ) protein antiserum (Rabbit #661)

Nipah virus G protein antiserum (Rabbit #612)

Nipah virus N protein antiserum (Rabbit #366)

Pan-orbivirus NS2 antiserum (Rabbit #17)

Mammalian Othoreovirus isolate 21DIAPD41049-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto)

Mammalian Othoreovirus isolate 21DIAPD41051-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto)

Mammalian Othoreovirus isolate 21DIAPD41117-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto)

Mammalian Othoreovirus isolate 21DIAPD41162-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto)

Live, frozen pdmH1N1 swine influenza virus, A/swine/England/1353/2009. Infected allantoic fluid stored at -80oC.

The end-user provided virus (e.g. as a tick homogenate) will be used to experimentally infect castor bean tick nymphs (Ixodes ricinus). The nymphs will be infected by micro-capillary inoculation into the coxal plate of the second pair of legs (transcoxal infection) using a digital microinjector system. First, 100 nymphs will be used for evaluation of the virus replication dynamics. Based on the obtained results, tick-derived virus stock will be generated from an additional 100 nymphs and provided to the end-user.

The end-user provided virus (e.g. as a tick homogenate) will be used to experimentally infect adult castor bean ticks (Ixodes ricinus). The ticks will be infected by micro-capillary inoculation into the coxal plate of the second pair of legs (transcoxal infection) using a digital microinjector system. First, 100 ticks will be used for evaluation of the virus replication dynamics. Based on the obtained results, tick-derived virus stock will be generated from an additional 100 ticks and provided to the end-user.

Bundle of freeze-dried tick-borne encephalitis virus (TBEV) isolates representing the diversity of the virus in Central Europe and covering various isolation sources (tick, rodent, milk).

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the G2 protein and S segment from Rift Valley Fever virus and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the Helicase region from Tick borne encephalitis virus and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.